A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Uncontrolled Asthma

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/246/25/29

Funding

  • Amgen, Inc ( Award # ): $15,250.00